Inventor · disambiguated record
Ning Yin
Also filed as: YIN NING
15 granted patents·21 pending applications·40 citations·filing 2013–2025
91Inventor score
Files withCUBIST PHARM INC19C4 THERAPEUTICS INC10HANGZHOU JIJING PHARMACEUTICAL TECH LIMITED2PAQ THERAPEUTICS INC2REVOLUTION MEDICINES INC2
Top patents by PatentIndex Score
36 records- 0193US11691972B2Compounds for targeted degradation of BRD9C4 THERAPEUTICS INC·Filed 2021·Granted Jul 4, 2023·5 cites·10 claims
- 0293US8809314B1Cephalosporin compoundCUBIST PHARM INC·Filed 2013·Granted Aug 19, 2014·16 cites·7 claims
- 0389US12157735B2Compounds for targeted degradation of BRD9C4 THERAPEUTICS INC·Filed 2022·Granted Dec 3, 2024·1 cites·23 claims
- 0488US12049464B2Compounds for targeted degradation of BRD9C4 THERAPEUTICS INC·Filed 2022·Granted Jul 30, 2024·1 cites·11 claims
- 0588US8962843B21,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitorsCUBIST PHARM INC·Filed 2013·Granted Feb 24, 2015·3 cites·5 claims
- 0686US8916709B21,2,4-oxadiazole and 1,2,4-thiadiazole β-lactamase inhibitorsCUBIST PHARM INC·Filed 2013·Granted Dec 23, 2014·4 cites·20 claims
- 0783US8969570B2Beta-lactamase inhibitorsCUBIST PHARM INC·Filed 2013·Granted Mar 3, 2015·3 cites·15 claims
- 0882US8940897B21,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitorsCUBIST PHARM INC·Filed 2013·Granted Jan 27, 2015·1 cites·5 claims
- 0982US8933233B21,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitorsCUBIST PHARM INC·Filed 2013·Granted Jan 13, 2015·1 cites·5 claims
- 1082US8933232B21,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitorsCUBIST PHARM INC·Filed 2013·Granted Jan 13, 2015·1 cites·5 claims
- 1182US8927724B2Isoxazole beta-lactamase inhibitorsCUBIST PHARM INC·Filed 2013·Granted Jan 6, 2015·3 cites·39 claims
- 1281US8962844B21,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitorsCUBIST PHARM INC·Filed 2013·Granted Feb 24, 2015·1 cites·5 claims
- 1381US2025084081A1Compounds for targeted degradation of brd9C4 THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1479US12421220B2Bicyclic-substituted glutarimide cereblon bindersC4 THERAPEUTICS INC·Filed 2024·Granted Sep 23, 2025·0 cites·26 claims
- 1579US2025382285A1Bicyclic-substituted glutarimide cereblon bindersC4 THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1679US2025368631A1Bicyclic-substituted glutarimide cereblon bindersC4 THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1772US2015031659A11,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitorsCUBIST PHARM INC·Filed 2014·Application pending·0 cites
- 1871US2024139185A1Compounds that participate in cooperative binding and uses thereofREVOLUTION MEDICINES INC·Filed 2023·Application pending·0 cites
- 1969US12404285B2KRAS G12D proteolysis targeting chimerasPAQ THERAPEUTICS INC·Filed 2024·Granted Sep 2, 2025·0 cites·30 claims
- 2069US2025051364A1KRAS G12D Proteolysis Targeting ChimerasPAQ THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2168US2015031665A11,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitorsCUBIST PHARM INC·Filed 2014·Application pending·0 cites
- 2267US2015031666A11,2,4-oxadiazole and 1,2,4-thiadiazole beta-lactamase inhibitorsCUBIST PHARM INC·Filed 2014·Application pending·0 cites
- 2367US2015038478A1Beta-lactamase inhibitorsCUBIST PHARM INC·Filed 2014·Application pending·0 cites
- 2466US9108966B2Beta-lactamase inhibitorsCUBIST PHARM INC·Filed 2014·Granted Aug 18, 2015·0 cites·3 claims
- 2565US2014323459A1Isoxazole beta-lactamase inhibitorsCALIXA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 2664US2015031660A11,2,4-oxadiazole and 1,2,4-thiadiazole beta-lactamase inhibitorsCUBIST PHARM INC·Filed 2014·Application pending·0 cites
- 2763US2025121070A1Compounds for the targeted degradation of smarca2C4 THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2862US2020197391A1Compounds that participate in cooperative binding and uses thereofREVOLUTION MEDICINES INC·Filed 2019·Application pending·0 cites
- 2961US2025051282A1Compounds for treating polyq-related neurodegenerative disordersHANGZHOU JIJING PHARMACEUTICAL TECH LIMITED·Filed 2022·Application pending·0 cites
- 3060US2015025053A1Cephalosporin compoundCUBIST PHARM INC·Filed 2014·Application pending·0 cites
- 3159US2024245677A1Selected compounds for targeted degradation of brd9C4 THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3258US2024100172A1Methods and compounds for targeted autophagyHANGZHOU JIJING PHARMACEUTICAL TECH LIMITED·Filed 2021·Application pending·0 cites
- 3357US2015038479A1Isoxazole beta-lactamase inhibitorsCUBIST PHARM INC·Filed 2014·Application pending·0 cites
- 3454US2015038482A1Isoxazole beta-lactamase inhibitorsCUBIST PHARM INC·Filed 2014·Application pending·0 cites
- 3550US2021198256A1Compounds for the degradation of brd9 or mth1C4 THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3647US2014315876A1Beta-lactamase inhibitorsCUBIST PHARM INC·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ning Yin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →